Loading clinical trials...
Loading clinical trials...
A Multimodal Prognostic Model for Advanced Pancreatic Ductal Adenocarcinoma Patients: a Retrospective and Prospective, Observational, Multicenter Study.
Conditions
Locations
1
China
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
Start Date
March 2, 2025
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2027
Last Updated
January 28, 2026
NCT07542041
NCT07030283
NCT07303465
NCT06040541
NCT06639724
NCT07458347
Lead Sponsor
RenJi Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions